Agatha Jassem

{{Short description|Canadian clinical microbiologist}}

{{Multiple issues|

{{Third-party|date=September 2021}}

{{Undisclosed paid|date=November 2022}}

}}

{{Infobox person

| name = Agatha Jassem

| image =

| imagesize =

| caption =

| othername =

| birth_name =

| birth_date =

| birth_place =

| death_date =

| death_place =

| burial_place =

| nationality = Canadian

| alma_mater = University of British Columbia

| occupation = clinical microbiologist

| years_active =

| known_for =

| spouse =

| children =

| mother =

| father =

}}

Agatha Jassem is a Canadian clinical microbiologist and the program head of the Virology Lab at the British Columbia Centre for Disease Control Public Health Laboratory,{{Cite web|title=Agatha Jassem|url=http://www.bccdc.ca/our-research/people/agatha-jassem|access-date=2021-09-20|website=bccdc.ca|language=en-CA}} and a clinical associate professor in the Department of Pathology & Laboratory Medicine at the University of British Columbia in Vancouver, British Columbia, Canada.{{Cite web|title=Agatha Jassem|url=https://ubc-pathology.sites.olt.ubc.ca/faculty/agatha-jassem-2/|access-date=2021-09-20|website=Pathology|language=en-US}}{{Dead link|date=August 2023 |bot=InternetArchiveBot |fix-attempted=yes }}

Jassem obtained her PhD at the University of British Columbia, followed by a fellowship in Clinical Microbiology at the National Institutes of Health.{{Cite web|title=Agatha Jassem|url=https://ubc-pathology.sites.olt.ubc.ca/faculty/agatha-jassem-2/|access-date=2021-09-20|website=Pathology|language=en-US}}{{Dead link|date=August 2023 |bot=InternetArchiveBot |fix-attempted=yes }} Her research focuses the detection of healthcare-and community-associated infections, emerging pathogens, and drug resistance determinants.

During the COVID-19 pandemic response, Jassem led research efforts on COVID-19 breakthrough infections from vaccinated individuals,{{Cite web|title=COVID-19 Smiles – The Study of Vaccine Escape Mutants {{!}} COVID-19 Research|url=https://covid19.research.ubc.ca/research/covid-19-smiles-study-vaccine-escape-mutants|access-date=2021-09-20|website=covid19.research.ubc.ca}}{{Cite web|date=2021-05-21|title=COVID-19 research initiatives at UBC among those funded by first-time partnership|url=https://www.med.ubc.ca/byline-date-only/covid-19-research-initiatives-at-ubc-among-those-funded-by-first-time-partnership/|access-date=2021-09-28|website=UBC Faculty of Medicine|language=en-US}} SARS-CoV-2 population level seroprevalence,{{Cite web|title=Population-Based Study Of Coronavirus Antibody Cross-Reactivity To Inform SARS-CoV-2 Seroprevalence {{!}} COVID-19 Research|url=https://covid19.research.ubc.ca/research/population-based-study-coronavirus-antibody-cross-reactivity-inform-sars-cov-2|access-date=2021-09-20|website=covid19.research.ubc.ca}} antibody response {{Cite web|title=Characterizing Antibody Response to Emerging COVID-19 Virus (CARE COVID-19) {{!}} COVID-19 Research|url=https://covid19.research.ubc.ca/research/characterizing-antibody-response-emerging-covid-19-virus-care-covid-19|access-date=2021-09-20|website=covid19.research.ubc.ca}} as well as collaborating on research on securing reagents for COVID-19 during world-wide shortages,{{Cite web|title=Securing Reagent Supplies and Scaling COVID-19 {{!}} COVID-19 Research|url=https://covid19.research.ubc.ca/research/securing-reagent-supplies-and-scaling-covid-19|access-date=2021-09-20|website=covid19.research.ubc.ca}} and the role of ACEII. {{Cite web|title=Prognostication of ACE II Receptor (PACEiiR) {{!}} COVID-19 Research|url=https://covid19.research.ubc.ca/research/prognostication-ace-ii-receptor-paceiir|access-date=2021-09-20|website=covid19.research.ubc.ca}}